Feb 23, 2022 7:00am EST NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
Feb 14, 2022 7:00am EST NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer
Feb 11, 2022 2:00am EST NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
Feb 08, 2022 7:00am EST NeoGenomics to Participate Virtually in Multiple Upcoming Institutional Investor Conferences
Feb 02, 2022 4:05pm EST NeoGenomics Schedules its Fourth Quarter and Full Year 2021 Earnings Release for February 23, 2022
